医学
甲氨蝶呤
血癌
免疫分型
化疗
内科学
淋巴瘤
中枢神经系统
间变性淋巴瘤激酶
长春新碱
疾病
肿瘤科
癌症
免疫学
环磷酰胺
抗原
胸腔积液
恶性胸腔积液
作者
Denise Williams,Tetsuya Mori,Alfred Reiter,Wilhelm Woessman,Angelo Rosolen,Grażyna Wróbel,József Zsíros,Anne Uyttebroeck,Ildikó Márky,Marie-Cécile Le Deley,Laurence Brugières
摘要
Abstract In an international study of systemic childhood ALCL, 12/463 patients had CNS involvement, three of which had isolated CNS disease. Comparative analysis of CNS positive and negative patients showed no difference in ALK positivity, immunophenotype, presence of B symptoms or other sites of disease. The lymphohistiocytic variant was over represented in the CNS positive group (36% vs. 5%). With multi‐agent chemotherapy, including high dose methotrexate, Ara‐C and intrathecal treatment, the event free and overall survival of the CNS positive group at 5 years were 50% (95%CI, 25–75%) and 74% (45–91%), respectively with a median follow up of 4.1 years. Pediatr Blood Cancer 2013;60:E118–E121. © 2013 Wiley Periodicals, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI